HIGHLIGHTS
- who: Petter Angell Olsen et al. from the Unit for Cell Signaling, Cancer Stem Cell Innovation Centre (SFI-CAST), Oslo University HospitalRikshospitalet, Oslo, Norway, Department of Chemistry, University of Oslo, Oslo, Norway have published the paper: Implications of Targeted Genomic Disruption of b -Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0115496]. December 23, 2014 of /1371/
- what: The authors investigated the consequence of a complete b-catenin depletion in PA by using zinc-finger nucleases (ZFNs) to generate cell lines in which b- catenin is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.